Clinical trial Recruiting at 1 site Observational Ages 9 Months to 16

Evaluating quality of life and stigmatization in children with congenital melanocytic nevi before and after surgery

Official title: Quality of Life and Experience of Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision: a Prospective Study

Run by University Children's Hospital, Zurich · NCT02280889 · Data updated 2026-11-12

This study looks at how surgery for congenital melanocytic nevi affects the quality of life and feelings of being judged in children before and after the operation.

More Quality of Life (QOL) trials

Quick facts

Study typeObservational
Ages9 Months to 16 Years
SexAll
Enrollment100 (estimated)
SponsorUniversity Children's Hospital, Zurich
Academic / other
Locations1 site (Zurich)
StatusRecruiting
StartedMay 2013
Main results expectedDecember 2031
Study endsDecember 2031
Registry record updatedMarch 4, 2026
Trial IDNCT02280889 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 9 months to 16 years with congenital melanocytic nevi measuring at least 2 cm² who are undergoing surgical removal.

Probably not a fit

Patients with mental retardation, severe comorbidities, or those who have previously undergone treatments for CMN may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on children with congenital melanocytic nevi (CMN) who are scheduled for surgical excision. Participants will complete questionnaires assessing their quality of life and experiences of stigmatization before the surgery and again one year post-operation. The study aims to gather both self-reports from the children and proxy reports from their parents to evaluate the psychological and aesthetic impacts of the nevus and its removal. The findings will help to understand the necessity of surgical intervention from both medical and psychosocial perspectives.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the psychological benefits of nevus excision, improving the quality of life for affected children.

How similar studies have gone: While there is limited data on similar studies, the approach of evaluating quality of life and stigmatization in this context is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients with a congenital melanocytic nevi of at least 2 cm2 that will be removed surgically
* age between 9 months and 16 years

Exclusion Criteria:

* mental retardation of the child
* insufficient knowledge of the German language of both parents
* severe comorbidities
* previous therapies done for the CMN (dermabrasion, surgery, laser)

Where it's running

  • University Children's Hospital Zurich, Division of Pediatric Plastic and reconstructive Surgery
    Zurich, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.